N-Myc overexpression increases cisplatin resistance in neuroblastoma via deregulation of mitochondrial dynamics-Reference-Cited by-同舟云学术

N-Myc overexpression increases cisplatin resistance in neuroblastoma via deregulation of mitochondrial dynamics

Published:2016-12 Issue:1 Volume:2 Page:
ISSN:2058-7716
Container-title:Cell Death Discovery
language:en
Short-container-title:Cell Death Discovery

Author:

Casinelli Gabriella,LaRosa Jeff,Sharma Manika,Cherok Edward,Banerjee Swati,Branca Maria,Edmunds Lia,Wang Yudong,Sims-Lucas Sunder,Churley Luke,Kelly Samantha,Sun Ming,Stolz Donna,Graves J Anthony

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddiscovery201682.pdf

Reference74 articles.

1. Ambros PF, Ambros IM, Brodeur GM, Haber M, Khan J, Nakagawara A et al. International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer 2009; 100: 1471–1482.

2. Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11–30.

3. Park JR, Eggert A, Caron H . Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin North Am 2010; 24: 65–86.

4. Wagner LM, Danks MK . New therapeutic targets for the treatment of high-risk neuroblastoma. J Cell Biochem 2009; 107: 46–57.

5. Fong A, Park JR . HIGH-RISK NEUROBLASTOMA: a therapy in evolution. Pediatr Hematol Oncol 2009; 26: 539–548.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial signaling pathways and their role in cancer drug resistance;Cellular Signalling;2024-10

2. Assessment of Ferroptotic Cell Death and Related Treatment Targets in Neuroblastoma;The Anatolian Journal of General Medical Research;2024-08-12

3. Mitochondrial transfer from Adipose stem cells to breast cancer cells drives multi-drug resistance;Journal of Experimental & Clinical Cancer Research;2024-06-14

4. Mitochondrial metallopeptidase OMA1 in cancer;Advances in Cancer Research;2024

5. Mitochondrion: Main organelle in orchestrating cancer escape from chemotherapy;Cancer Reports;2023-12-27